634
Participants
Start Date
August 31, 2008
Primary Completion Date
October 31, 2014
Study Completion Date
September 30, 2016
Medtronic CoreValve® System
The Medtronic CoreValve® System device is designed to replace the native aortic valve without the requirement for open heart surgery and without concomitant surgical removal of the failed native valve in patients with symptomatic severe aortic stenosis who have an elevated surgical risk
Epworth Hospital, Melbourne
St. Vincents Sydney, Darlinghurst
Prince Charles Hospital, Chermside
Royal Adelaide Hospital, Adelaide
Monash Hospital, Clayton
St. Vincent's Melbourne, Fitzroy
Alfred Hospital, Melbourne
Royal Perth Hospital, Perth
Mercy Hospital, Auckland
Waikato Hospital, Hamilton
Lead Sponsor
Medtronic Australasia
UNKNOWN
Medtronic Cardiovascular
INDUSTRY